Plain-English translation of NCT06550596 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether Axolotl DualGraft, a dehydrated human amnion membrane (a thin tissue layer derived from human placenta), can help diabetic foot ulcers heal better when combined with standard wound care. Half of the participants will receive the membrane plus standard care, while the other half will receive standard care alone. The goal is to see if this treatment helps stubborn foot wounds close more completely.
Many people with diabetes develop foot ulcers that don't heal well with standard care alone, sometimes leading to serious complications. This trial exists to find out whether this treatment can help these wounds heal faster and reduce the need for more invasive interventions.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic weekly for the duration of the study. At each visit, your wound will be cleaned and measured to track healing progress. You'll be randomly assigned to either receive the healing membrane applied to your ulcer plus standard wound care, or standard care alone. You must wear an offloading device (like a special boot or shoe) as prescribed to protect the ulcer while it heals.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United States
Sponsor
Axolotl Biologix
Collaborators
SerenaGroup, Inc.
Enrollment target
~100 participants
Started
September 2024
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Bennett M Rogers
Axolotl Biologix
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.